[Radiotherapy of the prostate gland--old wine in a new bottle?]

Aebersold, D M (2006). [Radiotherapy of the prostate gland--old wine in a new bottle?]. Therapeutische Umschau, 63(2), pp. 151-6. Bern: Huber

Full text not available from this repository.

The outcome and morbidity in the treatment of prostate cancer by radiation therapy depends on the balance between tumour control and normal tissue damage. Recent technological advances have allowed to reduce the amount of normal tissue included in target treatment volumes. This diminishes morbidity and provides an opportunity for dose escalation, increasing tumour control rates. The new application techniques are discussed along with their integration in treatment concepts. Although there are no randomised studies to provide evidence of increased survival, the available evidence supports the hypothesis that the introduction of novel radiation techniques leads to survival rates equivalent to surgical series with sufficient safety.

Item Type:	Journal Article (Further Contribution)
Division/Institute:	04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology
UniBE Contributor:	Aebersold, Daniel Matthias
ISSN:	0040-5930
ISBN:	16514968
Publisher:	Huber
Language:	English
Submitter:	Factscience Import
Date Deposited:	04 Oct 2013 14:48
Last Modified:	02 Mar 2023 23:22
PubMed ID:	16514968
URI:	https://boris.unibe.ch/id/eprint/19934 (FactScience: 3012)